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Summary 
Fas is a cell surface protein that mediates apoptosis.  A mouse mutant, Ipr (lymphoproliferation), 
has a mutation in the Fas gene. In this report, we studied the expression and function of Fas 
in various subpopulations of mouse thymocytes. Abundant expression of Fas was detected on 
CD4+CD8 + double positive as well as CD4 §  or CD8 + single positive thymocytes in wild- 
type mice. Little or low levels of Fas were expressed in CD4-CD8-  double negative thymo- 
cytes except for the CD4-CD8-CD3 § phenotype, which expresses Fas as abundantly as double 
positive or single positive subsets.  On the other hand, no Fas expression was detected in any 
population of thymocytes from Ipr mice. When the wild-type thymocytes were treated with 
the agonistic anti-Fas  antibody, double positive cells from the wild-type mice were selectively 
killed by apoptosis, whereas, the single positive cells were resistant to its cytolytic activity despite 
their abundant expression of Fas. Unlike the apoptosis of thymocytes induced by glucocorticoid 
or T cell activator, the Fas-induced apoptosis  of thymocytes was enhanced by metabolic inhibi- 
tors such as cycloheximide. Furthermore, intraperitoneal administration of the anti-Fas antibody 
into mice caused rapid apoptosis  of thymocytes in vivo. 
T  lymphocytes respond  to  a  wide  variety  of foreign 
antigens, whereas they do not respond to self compo- 
nents. This repertoire of T  cells are generated during their 
development in the thymus (1). The interaction of immature 
CD3 +/low CD4 +  CD8 + thymocytes with epithelial stroma 
cells in the thymus induces positive selection of T  cells, in 
which T cells recognizing the self-MHC as recognition ele- 
ments are positively selected and leave the thymus for the 
periphery (2). The T  cells which do not undergo positive 
selection die by apoptosis.  The immature thymocytes are also 
subject to negative selection in which the high avidity inter- 
action of thymocytes with the thymic stromal cells eliminates 
the T cells that are potentially autoreactive (3). This process 
is called clonal deletion and proceeds by apoptosis.  In addi- 
tion to the selection mechanism in the thymus, mature T 
cells recognizing the self-components are extrathymically  elim- 
inated by apoptosis  (4). 
The Fas antigen (Fas) is a cell-surface protein with molec- 
ular mass of 45 kD, and it belongs to the TNF/nerve growth 
factor (NGF) 1 receptor family (5-7). Since agonistic anti-Fas 
antibodies or Fas ligand can induce apoptosis under most cir- 
cumstances (8-12),  the Fas ligand and Fas can be regarded 
as a death factor and its receptor (7). Fas is expressed in var- 
ious tissues  such as the thymus, liver,  heart and ovary (5), 
whereas the Fas ligand is abundant in activated splenocytes 
and the testis (9). Chromosomal mapping and molecular anal- 
yses of the Fas and Fas ligand genes have indicated that mouse 
mutants, lymphoproliferation (lpr) and generalized lympho- 
proliferative disease (gtd) carry mutations in the Fas and Fas 
ligand, respectively (13-15). Mice homozygous for these mu- 
tations have similar phenotypes (16). They accumulate a large 
number of abnormal T  lymphocytes (CD4-CD8-)  in the 
lymph nodes and spleen, and suffer from autoimmune dis- 
ease by producing autoantibody. Since lpr and gld are loss-of- 
function mutations of Fas and Fas ligand, these phenotypes 
indicate that the Fas and Fas ligand system is involved in the 
deletion process of autoreactive T  cells. 
To examine the expression and function of Fas in mice, 
we established an agonistic monoclonal antibody against mouse 
Fas that has cytotoxic activity in vitro and in vivo (8).  In 
this report, we examined the Fas expression of mouse thy- 
mocytes and  their  sensitivity to  the cytotoxic activity of 
the  antibody.  Although  most  thymocytes except for  the 
CD3- CD4- CD8 -  subpopulation  uniformly express  Fas, 
only CD4+CD8 + double positive (DP)  thymocytes were 
susceptible to the cytotoxic activity of the anti-Fas antibody. 
1 Abbreviations used in this paper: DN, double negative  cells; DP, double 
positive cells; gld, generalized lymphoproliferative  disease; Ipr, lym- 
phoproliferation; NGF, nerve growth factor; SP, single positive cells. 
Materials  and Methods 
Antibodies.  The hamster hybridoma Jo2 producing anti-mouse 
Fas antibody (8) was cultured in AIM-V medium, and the mono- 
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affinity chromatography on protein A-Sepharose as described (8). 
In some cases, the antibody was used after biotinylation (8).  Rat 
anti-CD5 monoclonal antibody (clone, 53-7.3) was purchased from 
PharMingen (San Diego, CA). PE-conjugated goat anti-hamster 
IgG and  streptavidin-TRICOLOR were purchased  from Caltag 
(San Francisco,  CA). Biotinylated or PE-conjugated rat anti-L3T4 
(CD4)  monoclonal antibody (cl.one, Gk  1.5)  were from Becton 
Dickinson  Immunocytometry Systems  (San  Jose,  CA).  FITC- 
conjugated  or  PE-conjugated  rat  anti-Lyt-2  (CDS)  monoclonal 
antibody (clone,  53-6.7)  were from Becton Dickinson  or Phar- 
Mingen, respectively.  FITC-conjugated rat anti-CD3 monoclonal 
antibody (145-2Cll)  was purchased from Boehringer Mannheim 
Corp.  (Indianapolis,  IN). 
Mice and Preparation of Thymocytes.  BALB/c-+ / +, MRL/MpJ- 
+/+, and MRL/MpJ-lpr/Ipr  mice were purchased from Shizuoka 
Laboratory Animal Cooperation (Hamamatsu, Japan). CBA/K1- 
+/+  and  CBA/Kl-lpr'g/Ipr'g  mice were  obtained  from Dr.  A. 
Matsuzawa (Laboratory Animal Research Center, Institute of  Med- 
ical Science, University of Tokyo, Tokyo, Japan). All mice used were 
3-7 wk old.  To prepare thymocytes, thymuses surgically excised 
from mice were pressed between glass  slides,  and the cells were 
suspended in RPMI 1640 medium containing 10% FCS. The cell 
suspension was then filtered through nylon mesh to remove debris. 
Flow Cytometry.  Single thymocytes were suspended in staining 
solution (PBS containing 2% FCS and 0.02% sodium azide),  and 
washed twice with the same solution. Aliquots of '~1@ cells were 
stained by incubation with optimal concentrations of the antibodies 
described above for 30 min at 4~  in 100 #1 of staining solution. 
After washing twice with staining solution, the cells were incubated 
Figure 1.  Flow  cytometric 
analysis of mouse thymocytes for 
Fas expression. (a) Fas expression 
in  subpopulations  of  mouse 
thymocytes. Single-cell  suspension 
from the thymuses of 5-wk-old 
mice (BALB/c and MKL-lpr/lpr) 
was prepared, and 106 cells were 
analyzed  by  three-color  flow 
cytometry on a FACScan  |  as de- 
scribed in Materials and Methods. 
The  panels  at  left  are  two- 
dimensional  representations  of 
mouse thymocytes for CD4 and 
CD8 expression. The expression 
of the Fas antigen was examined 
for 5,000 cells of the thymocyte subsets, CD4+  CD8 + (DP), CD4 + CDg- (CD4 SP), CD4- CDS+  (CD8 SP), and CD4-  CDg-  (DN), and is 
shown in the eight panels at right.  (b) Expression of Fas in DN thymocytes. Mouse thymocytes were incubated with PE-conjugated anti-CD4 and 
anti-CDS,  FITC-conjugated anti-CD3 and biotinylated anti-Fas antibody (Jo2), which was followed by incubation with streptavidin-TRI-COLOK. 
The DN thymocytes (CD4- CD8-) were divided into CD3- (R1 region) or CD3 + (R2 region) population (left), and the Fas expression in each popu- 
lation was examined (right). 
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The cells  were then washed twice with staining solution, suspended 
in 400 #1 of the same solution containing 5 #g/ml of propidium 
iodide, and analyzed by flow cytometry. Three-color flow cytom- 
etry was performed on a FACScan  |  (Becton Dickinson) equipped 
with a 488-nm argon laser. Data from 5,000 or more cells were 
collected and analyzed on a FACScan  |  using LYSIS II software. 
Cell Killing Assay.  Thymocytes  (2  ￿  10  6 cells) were incubated 
for various periods at 37~  with the purified Jo2 antibody in 0.5 
ml of RPMI 1640 medium containing 10% FCS. The cells were 
washed once with KPMI 1640 medium, and the dead cells were 
quantified  by flow cytometry after staining with 5 #g/ml propidium 
iodide. To examine  the DNA degradation, chromosomal  DNA was 
prepared from the thymocytes using a SepaGene kit from Sanko 
Junyaku (Tokyo,  Japan), and analyzed on an agarose gel in Tris- 
borate buffer (17). 
Results 
Expression of Fas in Mouse Thymocytes.  We previously es- 
tablished a hamster hybridoma (.1o2) producing anti-mouse 
Fas monodonal antibody, and showed that more than 95% 
of mouse thymocytes abundantly express Fas (8). In contrast, 
Fas expression was not observed in thymocytes from Ipr-mice 
(MRL/Mp-lpr/Ipr).  To examine the Fas expression in mouse 
thymocytes in more detail, thymocytes from BALB/c-+/+ 
and MRL-Ipr/Ipr were analyzed by three-color flow cytom- 
etry using antibodies against CD4, CD8 and Fas. As shown 
in Fig. 1, thymocytes from 5-wk-old wild-type and lpr mice 
had virtually the same composition of CD4- CDS-  double 
negative cells (DN), CD4 +  CD8 + DP, and CD4 +  CD8- or 
CD4-CD8 + single positive cells (SP), confirming that the 
lpr mutation does  not  cause  the  apparent  abnormality in 
thymocyte development  (18, 19). Each  subpopulation  of 
thymocytes  was then examined for the Fas expression. Double 
and single positive thymocytes from the wild-type mice uni- 
formly express Fas, and its intensity was almost identical be- 
tween the two populations. On the other hand, DN thymo- 
cytes hardly expressed Fas except for a minor subpopulation. 
This Fas-positive CD4-CD8-  subpopulation was found to 
be CD3 positive (Fig.  1 c). On the contrary, in accordance 
with the little expression  of the functional Fas mRNA in 
the thymus of Ipr mice (13), no thymocytes from lpr mice 
expressed  Fas on their surface. 
Cytotoxicity  of Anti-Fas  Antibody against  Thymocytes. The 
anti-Fas antibodyJo2 causes apoptosis in mouse WR19L cell 
transformants expressing Fas (8).  To examine whether this 
antibody has cytotoxic activity on mouse thymocytes, thymo- 
cytes  were  incubated  with  various  concentrations  of the 
purified anti-Fas  antibody at 37~  for 16 h in the presence 
of 30 #g/ml of cycloheximide. As shown in Fig. 2 a,  the 
thymocytes from wild-type mice were killed by anti-Fas an- 
tibody in a dose-dependent manner. On the other hand, the 
antibody  did not have any effect on the thymocytes  from CBA- 
Iprq/lpr cg, which express nonfunctional Fas on the cell sur- 
face (13). Fig. 2 b shows the kinetics of the thymocyte death 
process by anti-Fas antibody. The thymocytes from the wild- 
type mice were rapidly killed by anti-Fas antibody, and '~80% 
of them were dead after a 24-h incubation with 1.0 #g/ml 
of the anti-Fas antibody. On the other hand, when the thymo- 
cytes from CBA-Iprc~/lprcg were incubated with anti-Fas  an- 
tibody, most cells were still alive under the same conditions. 
To confirm that the death of the thymocytes  induced by anti- 
Fas antibody occurred by apoptosis, chromosomal DNA was 
prepared from the thymocytes after incubation with anti-Fas 
antibody, and analyzed by agarose gel electrophoresis.  As 
shown in Fig. 3, chromosomal DNA was fragmented after 
a 3-h incubation with anti-Fas antibody. After 6 h, most of 
the chromosomal  DNA was degraded in the step ladder fashion 
that is characteristic  of apoptosis.  As a control, thymocytes 
from the wild-type mice were treated for 6 h with the anti- 
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Figure  2.  The cytotoxicity  of 
anti-Fas antibody  to mouse thy- 
mocytes. (a) The dose-dependent 
cytotoxicity  of the anti-Fas anti- 
body. Thymocytes (106 cells) 
from BALB/c (shaded bars) or 
CBA-ll,  r'~/lpr'-~ (open bars) were 
incubated at 37~  for 16 h with 
various  concentrations  of purified 
anti-Fas antibody  (1 ng/ml to 1 
#g/ml) in  the  presence of 30 
#g/ml of cycloheximide.  There- 
after, the percentage  of dead cells 
was quantified  by FACS  |  analysis 
after staining  with propidium  io- 
dide. (b) Kinetics of the killing 
process of the thymocytes.  Thy- 
mocytes  from  BALB/c-+/+ (O, 
O) and CBA-Iprcg/Iprcg  (A,  A) 
were incubated  at 37~  for the in- 
dicated periods with (O, A) or 
without (Q, A) 1 #g/m1  ofanti- 
Fas antibody,  and the percentage 
of  dead  cells  was determined  as de- 
scribed above. Figure  3.  Fragmentation  of 
thymic chromosomal DNA  by 
anti-Fas  antibody. Thymocytes 
(2  x  106  cells) from  BALB/c 
mice were incubated at 37~  in 
0.5  ml of RPMI  medium con- 
taining 1 #g/ml of  the anti-Fas an- 
tibody and 30/~g/ml  cyclohexi- 
mide (lanes I-5).  At 0 (lane 1 ), 
1.5 (lane  2), 3.0 (lane  3), 4.5 (lane 
4), and 6.0 h (lane 5), the chro- 
mosomal DNA was analyzed by 
electrophoresis  on a 1.5% agarose 
gel.  Chromosomal DNA  from 
the thymocytes  incubated for 6 h 
without anti-Fas  antibody  (lane  6) 
or with 1 #g/ml of the anti-CD5 
antibody (lane 7) in the presence 
of 30 #g/ml cycloheximide  was 
also analyzed. 
CD5  antibody.  This treatment  did not cause any degrada- 
tion  of chromosomal  DNA  (Fig.  3). 
Apoptosis of thymocytes can be induced by various agents 
such as glucocorticoids or thymocyte activators (20-24). To 
characterize the apoptosis of thymocytes induced by anti-Fas 
antibody,  and  to distinguish  it  from  apoptosis  induced by 
other agents,  the thymocytes were incubated for 18 h  with 
either  anti-Fas  antibody,  dexamethasone  or a  combination 
of PMA and A23187 ionomycin. Both dexamethasone and 
PMA/ionomycin rapidly induced apoptosis of the thymocytes, 
and about 80% of them were dead after 18 h  (Fig. 4). Dexa- 
methasone  or PMA/ionomycin  also  killed  the  thymocytes 
from  Ipr'e/Iprce  mice  as  efficiently as  the  wild-type  thymo- 
cytes, but Jo2 did not induce apoptosis in the Fas-defective 
Iprce/lprce strain (Fig. 4). Furthermore, as previously reported 
(20-24),  the  apoptosis  induced  by  dexamethasone  or 
PMA/ionomycin was almost completely inhibited by cyclo- 
heximide, whereas it enhanced the apoptosis induced by anti- 
Fas  antibody. 
DP but Not SP Thymocytes Are Sensitive to Fas-Induced Apop- 
tosis.  As shown above, Fas is expressed in most thymocytes 
except for those with the CD4-CD8-CD3-  phenotype. To 
examine which subset of thymocytes are sensitive to the cyto- 
toxic activity of Jo2  antibody,  thymocytes were incubated 
150 
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Figure  5.  Selective killing of 
CD4+CD8 + thymocytes  by anti- 
Fas antibody. Thymocytes (2  x 
106  cells) from  BALB/c mice 
were incubated at 37~  for 16 h 
with  various concentrations of 
anti-Fas antibody in the presence 
of 30 mg/ml  of cycloheximide. 
After incubation, viable thymo- 
cytes  were analyzed  by two-color 
flow  cytometry  for CD4 and CD8 
expression. The cell number of 
each subpopulation  of the thymo- 
cytes, CD4+CD8+  (O),  CD4- 
CD8+ (A), CD4+CD8 -  ([-1), and CD4-CD8-  (O), after incubation 
with anti-Fas antibody is expressed  as a percentage  of that of the thymo- 
cytes incubated without  anti-Fas antibody. 
at 37~  for 16  h  with  various concentrations  of Jo2  anti- 
body in the presence of 30/zg/ml of cycloheximide, and the 
viable cells were analyzed by flow cytometry using anti-CD4 
and CD8 antibody. As shown in Fig. 5, the DP thymocytes 
were sensitive to the cytotoxic activity of the Jo2 antibody, 
and more than half of the DP thymocytes were killed within 
16 h  by the antibody at  a concentration of 100 ng/ml.  On 
the other hand,  the viability of either CD4 *CD8-  or CD4- 
CD8 § SP cells did not change after incubation with 1 #g/ml 
anti-Fas antibody. These results indicated that the SP thymo- 
cytes are resistant  to  Fas-induced  apoptosis,  although  they 
express Fas  as abundantly as CD4 +CD8 + DP thymocytes. 
In Vivo Apoptosis of Thymocytes  by Anti-Fas Antibody.  We 
showed that mice given an intraperitoneal injection of anti- 
Fas antibody rapidly died (8). Although this administration 
caused acute hepatic failure, we could not detect any histo- 
logical abnormality in the thymus 2 h  after injection of the 
antibody.  Since the thymocytes were sensitive to the cyto- 
toxic activity of the antibody in vitro,  we reexamined  the 
in vivo effect of the antibody on the thymus. As previously 
found,  when  100/zg  of the purified Jo2  antibody was  in- 
traperitoneally injected into the wild-type mice, most of them 
died within 3 h, but some survived for 6-7 h (8). Therefore, 
the thymus was removed at various intervals after injection 
with Jo2 antibody, and its chromosomal DNA was analyzed 
on an agarose gel electrophoresis.  As shown in Fig.  6,  the 
thymic DNA was partially fragmented at 3 h after injection 
Figure 4.  Characterization of 
apoptosis of the thymocytes in- 
duced by various agents. Thymo- 
cytes from CBA-+/+  (filled  and 
open  bars)  or  CBA-lprcs/Iprce 
(slashed and shaded bars) were in- 
cubated at 37~  for 18 h with 1.0 
#g/ml of anti-Fas antibody (]o2), 
1.0/zM dexamethasone  (Dex) or 
a mixture of 10 ng/ml of PMA 
and 0.5 #M ionomycin  in the pres- 
ence (open and slashed  bars) or ab- 
sence (filled  and shaded bars) of 30 
#g/ml of cycloheximide. 
Figure 6.  Apoptosis  in  the 
thymus induced by in vivo ad- 
ministration of anti-Fas antibody. 
3-wk-old  BALB/c  mice  (lanes  I-6) 
or MRL-lpr/lpr  mice (lane  8) were 
injected with 100 #g of  Jo2 anti- 
body. Thymic DNAs were pre- 
pared at 0 (lane I ), 0.5 (lane 2), 
1.0 (lane  3), 2.0 (lane  4), 3.0 (lane 
5), or 5.0 h (lane 6) after injec- 
tion of the Jo2 anti-Fas antibody. 
DNAs  were analyzed by  dec- 
trophoresis on a 1% agarose gel 
in TBE buffer containing 0.5 #g/ml of ethidium bromide. The thymic 
DNA prepared  from the wild-type mice at 5 h after injection of the same 
amount of the control hamster IgG (lane 7) or anti-CD5 antibody (lane 
9) was also analyzed. 
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ladder fashion after 5 h. On the other hand, when Jo2 anti- 
body (100 #g) was injected into lpr mice, or anti-CD5 anti- 
body (100 #g) was injected into the wild-type mice, no degra- 
dation of thymic chromosomal DNA was observed (Fig. 6). 
These results indicated that the thymocytes are specifically 
sensitive in vivo to the apoptosis-inducing activity of the anti- 
Fas antibody, although it takes more time than apoptosis in 
the liver,  which occurs within 2 h  (8). 
Discussion 
Recently, Drappa et al.  (25),  reported that most mouse 
thymocytes, including CD4-CD8-  cells, express Fas with 
the highest levels being in CD4 § CD8 + thymocytes. Here, 
we examined Fas expression using three color method, and 
confirmed its expression in most thymocytes. However, un- 
like the report by Drappa et al.  (25), the most T-precursor 
cells  (CD4-CD8-CD3-)  did  not  express  Fas, and little 
difference in the Fas expression levels was detected between 
DP and SP thymocytes. Our results suggest that the Fas ex- 
pression is induced at the stage from CD3-CD41~176  to 
CD31~  + and is thereafter expressed throughout 
the thymic development of mouse thymocytes. This distri- 
bution of Fas in mouse thymocytes is significantly different 
from that in human thymocytes (26, 27), where Fas or APO-1 
is not expressed (26),  or expressed weakly in CD4-CD8- 
DN and CD4+CD8 + DP thymocytes, but  not in CD4 + 
CD8-  or CD4-CD8 + SP cells (27). 
Since the loss-of-function mutations of Fas or Fas ligand 
causes lymphadenopathy and autoimmune disease (13, 14), 
it is likely that the Fas system is involved in the apoptotic 
process during the development, maturation, or turnover of 
T cells. Here, we showed that the peritoneal administration 
of anti-Fas  antibody into mice caused massive  apoptosis in 
thymocytes. Since most thymocytes are comprised of CD4 § 
CD8 + DP cells,  this  agreed with  the results  obtained in 
vitro, which showed that the DP thymocytes are selectively 
sensitive  to the cytolytic activity of the anti-Fas  antibody. 
These results suggest a role of Fas in the thymic T cell devel- 
opment, since apoptosis of thymocytes mainly occurs in the 
DP stage (28).  However, the Fas-induced apoptosis is sig- 
nificantly different from the apoptosis induced by activation 
of thymocytes, which may or may not represent negative se- 
lection. The apoptosis induced by activation of thymocytes 
by PMA and ionomycin was blocked by inhibitors of protein 
or RNA synthesis, whereas Fas-induced apoptosis was en- 
hanced by cycloheximide (Fig. 4). Furthermore, thymocytes 
from lpr-mice which do not express Fas can be killed by acti- 
vation with PMA and ionomycin, or anti-CD3 antibody (29, 
30).  Negative selection occurs when T cell receptors of im- 
mature CD4 +  CD8 + cells are engaged by exposure to self- 
antigen peptides complexed with self-MHC on thymic stroma 
cells (3).  Apoptosis of DP cells by anti-CD3 antibody was 
therefore proposed to reflect a model of negative selection 
(24, 31). However, this model does not explain the negative 
selection observed in transgenic mice overexpressing Bcl-2 
(32, 33).  In these mice, DP thymocytes are resistant against 
the anti-CD3-induced apoptosis in vitro, yet negative selec- 
tion is not affected or only marginally disturbed in vivo. The 
Fas-mediated apoptosis is only partially inhibited by Bcl-2 
(34), and Ipr or gld thymocytes undergo normal negative se- 
lection (35). Taken together, there may be two apoptotic mech- 
anisms for negative selection induced by TCK engagement; 
one pathway is sensitive to Bcl-2, while the other is resistant 
to Bcl-2,  and Fas may be involved in the latter pathway. In 
addition to the apoptosis that occurs during negative selec- 
tion, thymocytes which do not undergo positive selection 
die by apoptosis (programmed cell death) (1). Whether or 
not the Fas system is involved in this process remains to be 
elucidated. 
As found in human naive mature T cells (36, 37), CD4 + 
and CD8 + SP thymocytes could not be killed by anti-Fas 
antibody despite their high expression of Fas. These cells may 
be devoid of the apoptotic signal transduction system through 
Fas, or they express proteins that inhibit Fas-mediated apop- 
toffs. One candidate for such inhibitory protein is Bd-2 (38) 
which is abundantly expressed in SP thymocytes, but hardly 
expressed in DP thymocytes (39). However, the overexpres- 
sion of Bcl-2 only partially inhibits the Fas-mediated apop- 
tosis in various cell types (34). Since several Bcl-2-related pro- 
teins have been identified (40,  41),  it would be of interest 
to study whether they modulate Fas-mediated apoptosis. 
Recently, Alderson et al. (42) have reported that costimu- 
lation of human thymocytes with anti-Fas antibody and anti- 
CD3 causes the Fas-dependent proliferation of thymocytes. 
With mouse thymocytes, we detected only the cytolytic ac- 
tivity of the anti-Fas  antibody in the absence of anti-CD3 
antibody, and not the growth-promoting activity. Natural 
Fas ligand also caused only apoptosis in mouse thymocytes 
(our unpublished results). It is possible that human and mouse 
thymocytes respond differently to the anti-Fas  antibody or 
Fas ligand, or that stimulation of the TCR modified the Fas- 
mediated signal transduction system in the thymocytes. How- 
ever, it is more likely that the enhancement of the CD3-induced 
proliferation of human thymocytes by the anti-Fas  antibody 
is due to the inhibition of the anti-CD3-induced apoptosis 
of mature thymocytes (such as CD4 + or CD8 + SP thymo- 
cytes) by the anti-Fas antibody, and expansion of the rescued 
cells with anti-CD3  antibody. 
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